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Abstract. The structure, mechanical properties, and deformation behavior under static and 
cyclic tension of biofunctionalized biodegradable vascular grafts based on 
polyhydroxybutyrate/valerate and polycaprolactone were studied. It is shown that the 
modification gives rise to an almost twofold decrease of the elongation at break as well as the 
ultimate strength. It is shown that under cyclic loading the modification of grafts results in 
decreasing cyclic durability by more than twice. In doing so, the level of deforming stress 
decreases to a much lesser extent and is practically inferior to that for unmodified material. The 
analysis of principal strain ε1 and ε2 component distribution patterns in grafts of both types is 
carried out while the reason for the observed changes is discussed. 
1.  Introduction 
To date, clinical practice still lacks ready-to-use vascular prostheses (grafts) of small diameter suitable 
for in situ regeneration of blood vessels. They are of actuality for carrying out shunting operations 
with replacing damaged vessels. However, the use of synthetic non-biodegradable polymers for 
manufacturing vascular grafts of small diameter was not successful due to development of chronic 
inflammation, thrombosis and neointima hyperplasia [1, 2]. 
For manufacturing vascular prostheses in situ many natural and artificial biodegradable polymers 
are used [3]. Natural polymers possess high biocompatibility and in vivo are completely subjected to 
gradual degradation to non-toxic substances. However, they give rise to a pronounced immune 
response; also, they have poor manufacturability while their mechanical properties are far distinct 
from blood vessels [4]. On the other hand, synthetic polymers do not usually cause a strong immune 
response; possess appropriate mechanical characteristics and high processability while their 
disadvantage is low biocompatibility: the absence of sites which promote cell adhesion [3].  
Recently, a number of strategies have been developed to provide polymer surfaces the ability to 
selectively adhere endothelial cells in order to accelerate endothelization. Most of them are based on 
immobilization or fixation on the surface of specific cell adhesion proteins and bioactive peptides [3]. 
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Arginine-glycine-asparagine (RGD) is a cell adhesion site that presents in many extracellular matrix 
proteins [5]. This sequence is one of the key ligands for integrins — receptors that are responsible for 
cell adhesion, migration, proliferation, differentiation, and survival [6]. The RGD peptide can be 
considered as a common integrin binding motif. Compared to proteins, bioactive RGD-containing 
peptides possess a simpler structure and higher chemical stability. Due to artificial synthesis, it is 
possible to develop a variety of configurations of RGD peptides with low immunogenicity and 
different potential for interaction with cells.  
Biofunctionalization of synthetic materials allows one to create biomimetic surfaces capable of 
generating specific cellular responses. The incorporation of biologically active peptides into the 
tubular scaffolds during the electrospinning process in combination with providing the created 
structure with functional activity can change the architectonics of surface. The latter should affect their 
deformation behavior under cyclic loading. The aim of the work was to study the deformation 
behavior under static and cyclic loading of biofunctionalized biodegradable vascular grafts based on 
polyhydroxybutyrate/valerate and polycaprolactone without and after modification by RGD peptides. 
2.  Materials and research methods 
Tubular polymer matrices with a diameter 1.5 mm were fabricated by electrospinning with the use of a 
“Nanon-01A” device (MECC Co. Ltd, Japan). The composition of polyhydroxybutyrate/valerate 
(PHBV) polymers with 10 % valerate (Sigma-Aldrich, USA) and polycaprolactone (PCL) with a 
molecular weight of 80,000 kDa (Sigma-Aldrich, USA) were employed. Nonpolar organic chloroform 
ChP (Vecton, Russia) was used as a solvent. The ratio of polymers in solution made 1:2. 
Hexamethylene diamine, glutaraldehyde, ninhydrin, ascorbic acid (Sigma-Aldrich, USA) and RGD 
(NanoTech-S, Russia) were used for surface modification of the polymer tubular frameworks made of 
the PHBV/PCL with the RGD peptides. First, the frameworks were treated with a 10 % solution of 
hexamethylenediamine in a water solution of isopropanol (1:1 ratio). The treatment was conducted at 
37 °C for 30 min which reduced the modification time twice [7, 8]. For the further treatments, each 
graft was put horizontally in a separate reactor (with a volume of 15 ml) with constant swaying. 
Static tension tests were carried out with the use of a Zwick/Roell universal testing machine (Zwick 
GmbH, Germany). The force gauge of a nominal 50 N capacity was employed with cross head 
velocity 10 mm/min. The tensile strength was estimated as the maximum tensile stress (MPa) before 
the onset of fracture. Elastic properties were estimated by the relative elongation at break (%) and 
Young's modulus (MPa). 
The structure of the inner grafts’ surface as well as wall thickness of non-woven tubular 
PHBV/PCL frameworks (at observation area of 0.5 × 0.5 mm) without and after the RGD peptides 
modified was studied using S-3400N scanning electron microscope (Hitachi, Japan) under high 
vacuum. For the observation, specimens were sprayed with gold and palladium foils with the help of a 
SC-7640 vacuum unit (Quorum Technologies, England). 
The Digital Image Correlation technique (DIC) was used to analyze the deformation behavior of 
loaded vascular grafts. The VIC 3D system (Correlated Solutions) was employed. Specimens in the 
initial and modified state were loaded at static tension with the use of an Instron 5582 
electromechanical testing machine. For this, fragments 60 mm long were cut out from tubular blanks. 
Then fine paint particles were sprayed with the use of an airbrush to form a contrast speckle pattern. 
The flattened (initially tubular shaped) specimens after clamping in grips had a strip-like shape. This is 
motivated by the fact of fiber damaging being cut along the axis. For this reason they became 
extremely heterogeneous and their elongation at failure was noticeably reduced. Then, such specimens 
were clamped into wedge grips and stretched at the loading rate 10 mm/min. Surface images were 
recorded every 10 seconds with the help of Canon EOS 700 digital SLR camera equipped with a 
telescopic lens. Further, using the DIC technique strain fields were calculated. Then dependencies of 
the average principal strains ε1 and ε2 versus tensile strain were constructed. 
To study the deformation behavior of specimens under cyclic tension a tubular graft was cut along 
the axis. Dog-bone shape specimen had the dimension shown in figure 1a. One of the folds oriented 
AMEM 2019
IOP Conf. Series: Materials Science and Engineering 731 (2020) 012004
IOP Publishing
doi:10.1088/1757-899X/731/1/012004
3
 
 
 
 
 
 
along the specimen axis remained in the center (Figure 1b). However the latter did not affect their 
deformation behavior. A speckle pattern consisted of black alkyd paint spots over white background 
and was deposited to the outside surface of the specimen (Figure 1b). 
 
 
 
 
Figure 1. Dog-bone shape specimen sketch (a) and speckle pattern photograph (b) of a vascular graft. 
 
The tests were carried out with the use of a Makron servo-hydraulic machine (Biss, India). The 
maximum cross head displacement is 60 mm with the accuracy of 1 μm. Specimens were tested by 
blocks of 100 cycles with the control over the grip movement (control by deformation). The amplitude 
of the cross head displacement was equal to 2 mm. After each cyclic loading block the surface was 
imaged. Then, the cross head was displaced to compensate the specimen loosening that took place 
during the cyclic loading. The average elongation of the specimens during 1 block of cycling was 
0.25 mm, i.e. for every 100 cycles the specimen was extended by ~ 1.25 %. Canon EOS 700D camera 
with an EF 70-300 mm telephoto lens was used. The necessary zoom was ensured by two macrolenses 
(+1, +2 diopters). 
3.  Results and discussion 
Modification density of the prostheses’ surface with the RGD peptides at the treatment for 30 minutes 
was 6.3 nM/cm2. The presence of peptides on the polymer surface was confirmed with the use of the 
Sakaguchi test over arginine presence [7, 8]. The specimen was remained colored after their washing 
that indicated covalent bonding of the peptide. A control specimen containing no RGD peptide stained 
light yellow; its coloring removed upon washing. Thus, the efficiency of the RGD peptide 
modification of the PHBV/PCL tubular framework surfaces at the modification time 30 minutes was 
confirmed.  
The PHBV/PCL grafts in both states possess a highly porous structure with a wall thickness 170–
250 μm consisting of homogeneous fibers (Figure 2). The average fiber diameter and average pore 
area in the grafts were 2.63 ± 1.14 μm and 47.13 ± 23.0 μm2, respectively, with the average porosity of 
~50.0 %. 
Stiffness is a particularly crucial indicator for the subsequent vessel compliance into which the 
prosthesis is planned to be implanted. Significant discrepancies in these parameters of the prosthetic 
vessel and vascular one may subsequently provoke neointima hypertrophy or thrombosis. Therefore, 
the stiffness diminishing was one of the main missions at PHBV/PCL based vascular grafts 
modification by the RGD peptides. It is shown that modification of the PHBV/PCL grafts with the 
RGD peptides gives rise to variation of their physic-mechanical properties (Table 1): a 1.7-fold 
decrease in elongation at break takes place against a 1.6-fold decrease in stiffness in regard to the 
unmodified analogues (p < 0.05). 
Table 1. Physico-mechanical properties of biodegradable vascular grafts without and after RGD modification 
Specimen Tensile strength, MPa Young's modulus, MPa Elongation at break, % 
PHBV/PCL 7.1 28.0 431.3 
PHBV/PCL + RGD 1.8 17.8 248.9 
a) 
b) 
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Figure 2. SEM micrographs of PHBV/PCL grafts without and after modification with the RGD 
peptides: cross section of the wall of the unmodified PHBV/PCL (a) ×200 and PHBV/PCL + RGD 
(b), ×150; the inner surface of the unmodified PHBV/PCL (c), ×1000, PHBV/PCL + RGD (d), ×1000 
3.1.  Mechanical behavior of biodegradable grafts under static loading 
Figure 3 shows the dependences of the principal strains ε1 and ε2 versus tensile strain for the grafts in 
both states. It is seen that, for the above reason, the elongation at break was reduced less than 2 times 
while the lowering patter was kept. The graph of the principal strain component ε1 looks less uniforms; 
in the case of the nonmodified graft while the inclination angle is slightly lower (Figure 3a). However, 
the graphs of another component ε2 differ significantly (Figure 3b). Thus, this deformation parameter 
turned out to be very sensitive to the structural changes happened. To understand the observed 
differences the maps of the deformation component distribution were then analyzed. 
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Figure 3. Diagrams of the principal stain ε1 (a) and ε2 (b) versus tensile strain at static tension of 
vascular grafts specimens without (initial) and after the modification (modified) 
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Maps of the principal strains ε1 (a) and ε2 distribution of the initial state and modified grafts at 
relative strain 20 % are given in figure 4. It is seen that the onset of plastic deformation is not 
accompanied by any pronounced strain localization (not taking into account the regions in the middle 
specimen where some extreme values are evident; however, they are related to the shrinkage of the 
half folded tube). The pattern of ε2 component distribution shows in the modified graft (which 
possesses less ductility) exhibits less uniformity (Figure 4d). By the authors opinion the latter is due to 
the heterogeneous structure of the modified graft. 
 
 
  
a b 
  
c d 
Figure 4. Maps of ε1 and ε2 distribution of vascular grafts without and after the modification (c, d); 
static stretching; strain level 20 %; a), c) ε1; b), d) ε2; a), b) without modification; c), d) after 
modification 
 
With further loading the specimens (in both states) are tightened; in doing so the strain distribution 
is fairly uniform in the initially half-folded tube specimens. To a greater extent this is related to the ε1 
component distribution. However, another principal strain ε2 (Figure 5b,d) looks less uniform. Note, 
that in the modified grafts the average strain level is higher: in the middle part of the specimen it 
exceeds that for the nonmodified graft up to 2 times. 
 
 
  
a b 
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Figure 5. Maps of ε1 and ε2 distribution of vascular grafts without and after the modification (c, d); 
static stretching; strain level 80 %; a), c) ε1; b), d) ε2; a), b) without modification; c), d) after 
modification 
 
Generally, a similar deformation pattern is kept up to critical strains preceding specimens’ fracture 
(Figure 6). Despite high straining (the elongation at break exceeds 100%) bothe types of specimens 
fail without neck formation or any other form of strain macrolocalization. This is due to both i) tubular 
shape of the specimens and ii) fibrous structure of the material. 
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3.2.  Mechanical behavior of biodegradable grafts under cyclic loading 
The cyclic tension test data evidences for the nonmodied graft failure after 82 blocks of loading 
(100 cycles each). In so doing, the length of the specimen has enlarged by 202.5 %. The RGD peptides 
modified graft has failed after applying 33 cyclic loading blocks with relative elongation (at break) 
142.5 %. Thus, in contrast to the data of static tension tests (Table 1), the difference in the relative 
elongation has reduced from 1.73 down to 1.42 times. 
 
  
a b 
  
c d 
Figure 6. Maps of ε1 and ε2 distribution of vascular grafts without and after the modification (c, d); 
static stretching; a), c) ε1; b), d) ε2; a), b) without modification; c), d) after modification; a), b) without 
modification (deformation degree – 140 %); c), d) after modification (deformation degree – 96 %) 
 
On the other hand, under cyclic tension (at the displacement control loading), the magnitude of the 
applied load differs insignificantly. This means that regardless less cyclic resistance under used severe 
testing conditions they possess nearly equal baring capacity. In combination with the fact that 
mechanical properties of the modified material are closer to native vessels it brings promise of their 
wide practical applications. 
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Figure 7. Graph of the applied load versus the number of loading cycles for the nonmodified (ini) and 
modified (mod) graft specimens 
 
Figure 8 shows patterns of principal strain ε1 distribution with increasing cyclic loading. It is seen 
that in the nonmodifed graft no signs of strain localization are revealed almost 300 cycles prior to 
failure N = 8·103 (Figure 8 a,c,e,g). Only at “necking” tearing takes place with cracks arising from 
opposite sides of the dog-bone shaped specimen to give rise to the main crack propagation (Figure 8i). 
In the modified graft a strain macrolocalization is already fixed at the low cycle number N = 2·103. 
Soon, the tearing started being initiated from one of the edges (Figure 8f). In this case, layered pattern 
of specimen fracture is observed when the upper layer begins to break while the underlying layers 
maintain continuity (Figure 8h). Just after, the specimen withstands another 300 loading cycles and 
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fails (Figure 8j). The reason is obviously related to its heterogeneity induced by the structure 
modification. 
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Figure 8. Principle strain ε1 maps for the vascular graft without and after modification; cyclic 
stretching; The number of cycles: a, b) 100, c, d) 1000, e, f) 2000, g, h) 3000, i) 8000, j) 3300; a, c, d, 
g, i) without modification; b, d, f, h, j) after modification 
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4.  Conclusion 
The structure, mechanical properties, and deformation behavior of polymer grafts in the initial and 
modified state were studied. The used modification regime of polymer biodegradable tubular 
PHBV/PCL grafts with RGD peptides (during 30 minutes) did not result in a statistically significant 
variation of their surface structure. Moreover, after the modification, the stiffness of grafts and their 
elongation ability decreased. This has brought the physico-mechanical properties of vascular 
prostheses PHBV/PCL + RGD closer to ones of native vessels. 
Experimental studies on the deformation behavior of biodegradable grafts under static and cyclic 
tension was carried out. The analysis and visualization of strain fields by means of digital image 
correlation was conducted. It is shown that principal strain distribution patters correlates well with 
variation of mechanical properties, namely, the plastic flow stress and elongation at break. It is shown 
that principal strain component ε2 in the modified graft (possessing lower mechanical properties is 
distributed less uniformly while its level prior to failure is up to two times higher than that in the 
unmodified material. 
Regardless less cyclic resistance under used severe testing conditions the modified grafts possess 
nearly the equal baring capacity under cyclic tension. In combination with the fact that their 
mechanical properties are closer to native vessels it brings promise of their wide practical applications. 
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